One of the more interesting consequences of this past presidential election is Donald Trump’s nomination of Robert F. Kennedy, Jr., popularly known as RFK, as head of the Department of Health & Human Services (HHS).
As part of his campaign to “Make America Healthy Again,” RFK has pledged to root out corruption at the Food & Drug Administration (FDA). He is on record as a staunch critic of pharmaceutical companies and food producers who he believes have held too much sway over FDA’s decisions regarding the safety and efficacy of drugs and food additives.
If RFK is looking, as we trust he will be, what follows is a prime example of the political corruption of the FDA’s drug approval process.
Though there is no indication that the abortion pill, mifepristone, is currently on his radar, that drug is a prime candidate for review. What is more corrupt than its horrible safety record, further compounded by recent decisions by the FDA to water down regulations on distribution of the drugs at the insistence of the abortion industry and on the basis of studies supplied by that same industry?
Challenges to the integrity of the FDA’s regulatory review process were summarily dismissed under previous Democrat administrations and were thus exceedingly difficult to challenge in the courts. […]
— Read More: www.lifenews.com
